Grant: Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Université Laval
$97,928.00
Pathogenesis of myotonic dystrophy
EF 2008-09
Résumé
Myotonic dystrophy type 1 is the most frequent muscular dystrophy in adult,which affects 1/10,000. No curative treatments are presently available for this disease. The major objective of this proposal is to elucidate the mechanisms that cause Myotonic dystrophy. The results of this research is of major importance for the development of a specific treatment for this muscular dystrophy.
Programme
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
186522
Name
Puymirat Jack
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Muscular Dystrophy Canada (Toronto, Ontario)
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
Pathogenesis of myotonic dystrophy
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$97,928
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Keyworddelim
Muscular Dystrophy; Pathogenesis; Rna Splicing; Transgenic Mouse
Abstract
Myotonic dystrophy type 1 is the most frequent muscular dystrophy in adult,which affects 1/10,000. No curative treatments are presently available for this disease. The major objective of this proposal is to elucidate the mechanisms that cause Myotonic dystrophy. The results of this research is of major importance for the development of a specific treatment for this muscular dystrophy.
Competitiondate
200903
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Puymirat, Jack
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $97,928~ $0~